tm logo
GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 2,200 MG PER 220 ML (10 MG/ML)
Live/Registered
REGISTERED

on 08 Dec 2020

Last Applicant/ Owned by

Western Express Highway, Goregaon (E)

Mumbai, Maharashtra

IN

400063

Serial Number

88125549 filed on 20th Sep 2018

Registration Number

6217219 registered on 08th Dec 2020

in the Principal Register

Correspondent Address

Craig Kuchii, Esq.

Craig Kuchii, Esq.

INTELLECTUAL PROPERTY DEPT.

2 INDEPENDENCE WAY

PRINCETON NJ 08540

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 2,200 MG PER 220 ML (10 MG/ML)

medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the fo Read More

Classification Information


Class [010]
Medical Instrument Products


medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine


First Use Date in General

08th Jul 2020

First Use Date in Commerce

08th Jul 2020

Class [005]
Pharmaceutical Products


medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine


First Use Date in General

08th Jul 2020

First Use Date in Commerce

08th Jul 2020

Mark Details


Serial Number

No 88125549

Mark Type

No Service/Collective Mark

Attorney Docket Number

No STM-482US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.11.13 -

Two rectangles

26.11.21 -

Rectangles that are completely or partially shaded

26.17.09 -

Curved line(s), band(s) or bar(s)

Legal History


Show more

Status DateAction Taken
08th Dec 2020REGISTERED-PRINCIPAL REGISTER
04th Nov 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03rd Nov 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
23rd Oct 2020TEAS EXTENSION RECEIVED
13th Oct 2020STATEMENT OF USE PROCESSING COMPLETE
13th Oct 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
29th Sep 2020USE AMENDMENT FILED
29th Sep 2020TEAS STATEMENT OF USE RECEIVED
24th Apr 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22nd Apr 2020EXTENSION 2 GRANTED